BRUSSELS (Reuters) - The European Commission is in talks with four companies to secure a potential COVID-19 vaccine, President Ursula von der Leyen said on Thursday following an EU leaders' video conference.
The EU has already secured potential vaccines being developed by AstraZeneca, Sanofi and Johnson & Johnson. It has also said to be in talks with Moderna, CureVac and a partnership of Pfizer and BionTech.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!